pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 1
GRC-39815
Chronic Obstructive Pulmonary Disease (COPD)
Glenmark Pharmaceuticals Ltd
0 catalysts
Phase 2
GRC-54276
Bile Duct Cancer (Cholangiocarcinoma)
Ichnos Glenmark Innovation
0 catalysts
Phase 2
GRF-312
Keratoconjunctivitis Sicca (Dry Eye)
$GRFSGrifols SA
0 catalysts
Preclinical
GRI-0803
← prev
page 89 of 231
next →
131
Pain89
Neurology1
Systemic Lupus Erythematosus
$GRIGRI Bio, Inc.
0 catalysts
Phase 1
GRN-300
Triple-Negative Breast Cancer (TNBC)
Greenfire Bio LLC
0 catalysts
Phase 2
GS-030
Retinitis Pigmentosa (Retinitis)
GenSight Biologics SA
0 catalysts
Phase 1
GS-0321
Solid Tumor
$GILDGILEAD SCIENCES, INC.
0 catalysts
Phase 3
GS-100
Grace Science LLC
0 catalysts
Phase 1
GS-6791
Rheumatoid Arthritis
$GILDGILEAD SCIENCES, INC.
0 catalysts
Phase 2
GSK-101
Human Epidermal Growth Factor Receptor 2 Low Breast Cancer (HER2 Low Breast C…
Sodium channel protein type 9 subunit alpha
$GSKGSK plc
0 catalysts
Phase 2
GSK-4382276A
Seasonal Influenza
$GSKGSK plc
0 catalysts
Phase 2
GSK-5536522
Influenza A Virus, H5N1 Subtype Infections
$GSKGSK plc
0 catalysts
Phase 1
GT-01
Obesity
Gila Therapeutics Inc
0 catalysts
Phase 1
GTB-3650
Myelodysplastic Syndrome (Preleukemia)
$GTBPGT Biopharma, Inc.
0 catalysts
Phase 1
GTB-5550
Epithelial Ovarian Cancer
$GTBPGT Biopharma, Inc.
0 catalysts
Preclinical
GTC-3295
Alzheimer's Disease
Gismo Therapeutics Inc
0 catalysts
GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE
GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE (GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE)
RB HLTH
0 catalysts
GUANFACINE
GUANFACINE (GUANFACINE)
UNICHEM
0 catalysts
Phase 2
GV-200251
Cervical Cancer
GV20 Therapeutics LLC
0 catalysts
Preclinical
GW-01
Unspecified Cancer
Groovy Medicine Inc
0 catalysts
Preclinical
GXC-301
Lafora Disease (Unverricht Disease)
Genixcure Inc
0 catalysts
Preclinical
GXV-002
Pulmonary Arterial Hypertension
GEXVal Inc
0 catalysts
Phase 1
Gallium Maltolate
Recurrent Glioblastoma Multiforme (GBM)
$KMCMTitan Holdings Corp.
0 catalysts
Preclinical
Gene Therapies to Activate NAGLU for Mucopolysaccharidosis Type IIIB
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )
Neurogt Inc
0 catalysts
Preclinical
Gene Therapy Product
Chemotherapy Induced Peripheral Neuropathy
Navega Therapeutics Inc
0 catalysts
Preclinical
Gene Therapy for Alpha-Mannosidosis
Alpha-Mannosidosis
Eunice Kennedy Shriver National Institute of Child Health and Human Development
0 catalysts
Preclinical
Gene Therapy for Arginase 1 Deficiency
Hyperargininemia (Arginase I Deficiency)
UCLA Health System
0 catalysts
Preclinical
Gene Therapy for Bone Fracture
Bone Fracture
Cedars-Sinai Medical Center
0 catalysts
Preclinical
Gene Therapy for Branched-Chain 2-Ketoacid Dehydrogenase Deficiency
Maple Syrup Urine Disease
Clinic for Special Children
0 catalysts
Preclinical
Gene Therapy for Limb-Girdle Muscular Dystrophy Type 2C/R5
Limb-Girdle Muscular Dystrophy
Evolyra Therapeutics
0 catalysts